Legislators question price of leukemia drugOctober 24, 2016Leukemia, Myelodysplasia, TransplantationPharmacyALLCML
Doc offers advice on choosing a frontline TKIOctober 6, 2016Leukemia, Myelodysplasia, TransplantationCML
Medicare doesn’t lower TKI costs enough, study suggestsOctober 4, 2016Leukemia, Myelodysplasia, TransplantationPharmacyCML
Ponatinib approved to treat CML, ALL in JapanSeptember 30, 2016Leukemia, Myelodysplasia, TransplantationPharmacyALLCML
EZH2 inhibitors could improve treatment of CML, studies suggestSeptember 16, 2016Leukemia, Myelodysplasia, TransplantationCML
Combo could provide cure for CML, team saysSeptember 9, 2016Leukemia, Myelodysplasia, TransplantationCML
NICE approves bosutinib for routine NHS useAugust 26, 2016Leukemia, Myelodysplasia, TransplantationPharmacyCML
Teva launches generic imatinib tablets in USAugust 8, 2016CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationPharmacyALLMyelodysplastic SyndromeCML
FDA clears kit for monitoring molecular response in CMLJuly 26, 2016Leukemia, Myelodysplasia, TransplantationCML
Cancer cell lines predict drug response, study showsJuly 8, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLALLCMLNon-Hodgkin Lymphoma
NICE recommends approval for bosutinibJuly 8, 2016Leukemia, Myelodysplasia, TransplantationPharmacyCML
Study: CMV doesn’t lower risk of relapse, deathJune 29, 2016AnemiaLeukemia, Myelodysplasia, TransplantationTransplantationAMLALLMyelodysplastic SyndromeCML
Team describes method of targeting LSCs in BC-CMLJune 24, 2016Leukemia, Myelodysplasia, TransplantationCML
